Perforomist
(BPXZSHHCUKRDHD-HTLUESNNSA-N)
Structure
- SMILES
- OC(=O)/C=C/C(=O)O.O=CNc1cc(ccc1O)[C@H](CN[C@@H](Cc1ccc(cc1)OC)C)O.O=CNc1cc(ccc1O)[C@H](CN[C@@H](Cc1ccc(cc1)OC)C)O.O
- Molecular Formula:
- C42H54N4O13
- Molecular Weight:
- 822.897
- Log P:
- 6.2937
- Hydrogen Bond Acceptor:
- 17
- Hydrogen Bond Donor:
- 11
- TPSA:
- 265.47
- CAS Number(s):
- N/A
Synonym(s)
1.
Perforomist
External Link(s)
Adverse Drug Event(s)
| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Drug ineffective | FAERS: 9 Canada Vigilance: 29 | Canada Vigilance US FAERS | |
| 2 | Nausea | FAERS: 7 | US FAERS | |
| 3 | Fatigue | FAERS: 5 | US FAERS | |
| 4 | Wrong technique in product usage process | FAERS: 3 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 5 | Asthenia | FAERS: 2 | US FAERS | |
| 6 | Asthma | FAERS: 2 Canada Vigilance: 3 | Canada Vigilance US FAERS | |
| 7 | Candidiasis | FAERS: 2 | US FAERS | |
| 8 | Dizziness | FAERS: 2 | US FAERS | |
| 9 | No adverse event | FAERS: 2 | US FAERS | |
| 10 | Product storage error | FAERS: 2 | US FAERS | |
| 11 | Throat irritation | FAERS: 2 | US FAERS | |
| 12 | Wheezing | FAERS: 2 | US FAERS | |
| 13 | Abdominal discomfort | FAERS: 1 | US FAERS | |
| 14 | Accidental exposure to product | FAERS: 1 | US FAERS | |
| 15 | Alopecia | FAERS: 1 | US FAERS | |
| 16 | Amnesia | FAERS: 1 | US FAERS | |
| 17 | Anxiety | FAERS: 1 | US FAERS | |
| 18 | Bronchospasm | FAERS: 1 | US FAERS | |
| 19 | Burning sensation | FAERS: 1 | US FAERS | |
| 20 | Chest discomfort | FAERS: 1 | US FAERS | |
| 21 | Constipation | FAERS: 1 | US FAERS | |
| 22 | Crying | FAERS: 1 | US FAERS | |
| 23 | Diabetes Mellitus | FAERS: 1 | US FAERS | |
| 24 | Drug effect delayed | FAERS: 1 | US FAERS | |
| 25 | Dysphonia | FAERS: 1 | US FAERS | |
| 26 | Dysuria | FAERS: 1 | US FAERS | |
| 27 | Epistaxis | FAERS: 1 | US FAERS | |
| 28 | Expired product administered | FAERS: 1 | US FAERS | |
| 29 | Flatulence | FAERS: 1 | US FAERS | |
| 30 | Frustration | FAERS: 1 | US FAERS | |
| 31 | Gastric Dilatation | FAERS: 1 | US FAERS | |
| 32 | Gastritis | FAERS: 1 | US FAERS | |
| 33 | Hernia | FAERS: 1 | US FAERS | |
| 34 | Malaise | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 35 | Medication Error | FAERS: 1 | US FAERS | |
| 36 | Middle insomnia | FAERS: 1 | US FAERS | |
| 37 | Nervousness | FAERS: 1 | US FAERS | |
| 38 | Ocular discomfort | FAERS: 1 | US FAERS | |
| 39 | Oropharyngeal pain | FAERS: 1 | US FAERS | |
| 40 | Paranasal sinus discomfort | FAERS: 1 | US FAERS | |
| 41 | Pneumonia | FAERS: 1 | US FAERS | |
| 42 | Product administration error | FAERS: 1 | US FAERS | |
| 43 | Product quality issue | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 44 | Respiratory Failure | FAERS: 1 | US FAERS | |
| 45 | Retching | FAERS: 1 | US FAERS | |
| 46 | Somnolence | FAERS: 1 | US FAERS | |
| 47 | Stress | FAERS: 1 | US FAERS | |
| 48 | Tremor | FAERS: 1 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 49 | Unevaluable event | FAERS: 1 | US FAERS | |
| 50 | Visual Impairment | FAERS: 1 | US FAERS | |
| 51 | Vomiting | FAERS: 1 | US FAERS | |
| 52 | Device occlusion | Canada Vigilance: 1 | Canada Vigilance | |
| 53 | Dysphemia | Canada Vigilance: 1 | Canada Vigilance | |
| 54 | Electrocardiogram abnormal | Canada Vigilance: 1 | Canada Vigilance | |
| 55 | Headache | Canada Vigilance: 1 | Canada Vigilance | |
| 56 | Palpitations | Canada Vigilance: 1 | Canada Vigilance | |
| 57 | Product complaint | Canada Vigilance: 1 | Canada Vigilance | |
| 58 | Product dose omission | Canada Vigilance: 1 | Canada Vigilance | |
| 59 | Syncope | Canada Vigilance: 1 | Canada Vigilance | |
| 60 | Tachycardia | Canada Vigilance: 1 | Canada Vigilance |
Powered by :
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120239
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.